The former CEO and chief nursing officer at Eureka Springs (Ark.) Hospital have filed lawsuits against the hospital and six commission members, alleging wrongful termination in November after reporting staff complaints about the chief financial officer.
Legal & Regulatory Issues
A federal judge in Texas dismissed a lawsuit alleging that Edinburg, Texas-based Cornerstone Regional Hospital submitted millions of dollars in fraudulent claims for operations performed by unlicensed foreign physicians, Law.com reported Dec. 11.
Texas' attorney general is suing a New York physician for providing a Texas woman with abortion-inducing drugs via telehealth.
House Republicans are investigating whether CVS Caremark, a leading pharmacy benefit manager, violated federal antitrust laws by allegedly blocking independent pharmacies from using cost-saving tools outside of its network, The Hill reported Dec. 12.
Eureka Springs (Ark.) Hospital received an immediate jeopardy warning Nov. 22 after surveyors found it lacked adequate emergency diagnostic laboratory services. The warning was lifted Dec. 3 after the hospital submitted a plan of correction, according to documents obtained by…
Advertisement
A New York operations manager was charged for allegedly conspiring to offer and pay kickbacks to physicians in exchange for ordering unnecessary brain scans.
Oroville (Calif.) Hospital agreed to pay $10.25 million to resolve allegations it violated the False Claims Act and the Anti-Kickback Statute, according to a Dec. 12 Justice Department news release.
A series of recalls from India-based company Glenmark Pharmaceuticals has raised concerns about the safety of drugs manufactured overseas and the FDA's role in ensuring public safety, ProPublica reported Dec. 12.
A Philadelphia judge ordered a new trial in a $45 million malpractice case against Temple Health on Dec. 5, calling the jury's original verdict in August "exorbitant." The case involves a patient who suffered brain damage after aspirating food following…
The Federal Trade Commission and the Justice Department's antitrust division on Dec. 11 withdrew the Antitrust Guidelines for Collaborations Among Competitors.